ArticleBMC musculoskeletal disorders2025
A threshold effect of Apolipoprotein A1 levels on systemic inflammatory response index in individuals with osteoporotic fractures: a cross-sectional study.
Article in BMC musculoskeletal disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundChronic inflammation and lipid metabolism are closely associated with osteoporotic fractures. Previous studies have reported associations between Apolipoprotein A1 (ApoA1) and inflammatory markers in specific inflammatory diseases. Nevertheless, the association between ApoA1 and the Systemic Inflammatory Response Index (SIRI) has been scarcely investigated in populations with osteoporotic fractures. We therefore conducted this cross-sectional study to examine this association.
methodsIn this cross-sectional study, 2067 patients with osteoporotic fractures (OPF) needing surgical intervention at Kunshan Hospital affiliated with Jiangsu University from January 2017 to July 2022 were enrolled. The relationship between serum ApoA1 concentrations and SIRI was evaluated and described using linear regression models and smooth curve fitting. A two-piecewise linear regression model was employed to identify the inflection point. Additionally, stratified and univariate analyses were conducted.
resultsAfter accounting for potential confounders, serum ApoA1 concentrations were discovered to have an inverse association with SIRI (β = -0.822, 95% CI (-1.491, -0.153), P = 0.016). Moreover, the smoothed plot revealed a non-linear relationship between serum ApoA1 concentrations and SIRI, with the inflection point observed at ApoA1 levels of 1.25 g/L. The magnitude of effect and 95% CI on either side of the inflection point were -2.258 (-3.541, -0.974) and 0.512 (-0.706, 1.729), respectively. In addition, further subgroup analyses reinforced the consistency of the association between ApoA1 concentrations and SIRI.
conclusionsOur study revealed a threshold effect between serum ApoA1 levels and SIRI in patients with OPF, demonstrating a negative correlation between ApoA1 and SIRI within a specific range. However, further research is warranted to expand and validate these findings.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.